The majority of novel targeted anticancer drugs are weakly basic molecules with poor aqueous solubility which ultimately compromise their oral bioavailability. Lenvatinib (Lnv) is …
T Chavan, D Kanabar, K Patel, TM Laflamme… - Bioorganic & Medicinal …, 2024 - Elsevier
Liver cancer is a complex disease that involves various oncoproteins and the inactivation of tumor suppressor proteins (TSPs). Gankyrin is one such oncoprotein, first identified in …
D Kanabar, EI Kane, T Chavan… - Future Medicinal …, 2024 - Taylor & Francis
Background: Gankyrin is an ankyrin-repeat protein that promotes cell proliferation, tumor development and cancer progression when overexpressed. Aim: To design and synthesize …
S Moradi, T Ehrig - Journal of Molecular Pathology, 2022 - mdpi.com
Gankyrin has a household function in essentially all cells by acting as a chaperone in the assembly of the 26S proteasome, but also functions as a tumor-promoting protein by …
А Юсуф, ЗИ Муртазаева, ДБ Тухтаев… - Журнал химии товаров …, 2023 - jcgtm.org
Аннотация Азотсодержащие гетероциклические соединения-триазолы являются важным селективным классом производных в химиотерапии против линий опухолевых …
Gankyrin is a seven ankyrin repeat containing oncoprotein overexpressed in numerous cancer types such as lung, breast, prostate, colorectal, and many more. Gankyrin binds to S6 …
The essential pathways that regulate neurodevelopmental processes involve a myriad of post-translational modifications (PTMs) such as ubiquitylation that systematically control …